DNA RNA and Cells

01 Jun 2010 Tekmira Reports Complete Protection from Deadly Ebola Virus in Nonhuman Primates with SNALP-RNAi
30 May 2010 Targeted Genetics' Partner Celladon Corporation Reports Positive Phase 2 Clinical Trial Data at Heart Failure Association Annual Meeting
26 May 2010 CoDa Therapeutics Achieves Positive Phase 2 Efficacy of NEXAGON in Chronic Venous Leg Ulcers
24 May 2010 Neuralstem Updates Clinical Trial Progress
22 May 2010 VIRxSYS Presents Results from Multiple Studies at the 13th ASGCT Annual Meeting
20 May 2010 Jennerex Reports Positive Phase 1 Results for JX-594 Administered Intravenously
20 May 2010 Amsterdam Molecular Therapeutics Reports Promising Data From Cholesterol Lowering Gene Therapy Study
20 May 2010 New Data from Adrenoleukodystrophy (ALD) Pilot Study Presented at American Society of Gene and Cell Therapy Show Three-Year Disease Stabilization of Patients
19 May 2010 Oncolytic viruses mediating anti-tumor immunity in human cancer patients published by Oncos Therapeutics and University of Helsinki Oncos Therapeutics
17 May 2010 First Patient Treated in Aastrom's U.S. Phase 2 Catheter Clinical Trial in Dilated Cardiomyopathy
14 May 2010 Geron Annonces Positive Study Data on GRNCM1
14 May 2010 Neotropix Announces Enrollment of Patients in NCI-Sponsored Phase II Clinical Trial for Small Cell Lung Cancer
13 May 2010 Fibrocell Science, Inc. Initiates Histology Study of azficel-T
11 May 2010 Tekmira Pharmaceuticals Announces Multi-Year Agreement with Bristol-Myers Squibb
10 May 2010 Cytori Reports Stem & Regenerative Cells from Body Fat Produce Statistically Significant Improvement in Heart Function in Chronic Ischemia Trial
07 May 2010 AVI BioPharma and Collaborators Publish Data From Preclinical Studies Demonstrating the Antimicrobial Efficacy of PMO Oligomers Against Burkholderia Cepacia Complex in The Journal of Infectious Diseases
06 May 2010 Quark Pharmaceuticals Development Partner Pfizer Presents In Vivo Activity of PF-04523655 at ARVO
06 May 2010 TCA Cellular Presents Promising Adult Stem Cells Treatment in Heart Attack Victims at SCAI Conference
05 May 2010 Osiris Resumes Enrollment in Stem Cell Trial for Crohn's Disease Following Positive Interim Analysis
05 May 2010 MDRNA, Inc. Reports Novel Target Specificity Characteristics of Its Proprietary UsiRNA Technology for RNAi-based Therapeutics
05 May 2010 Novocell Becomes ViaCyte, Inc., as it Accelerates Pre-Clinical Development of a Stem Cell Derived Treatment for Diabetes
04 May 2010 NOXXON Announces the Completion of the First-in-Human Clinical Trial with Spiegelmer NOX-A12
03 May 2010 StemCells, Inc.'s Phase I Batten Trial Data Featured at American Association of Neurological Surgeons Annual Meeting
30 Apr 2010 Biocancell Receives U.S. FDA Approval to Continue Phase IIb Superficial Bladder Cancer Clinical Trial and Interim Results

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up